Psychiatry and Psychology [F] » Mental Disorders [F03] » Neurocognitive Disorders » Cognition Disorders
Description
Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. MeSH
Hierarchy View
Subtype Terms (3)
Auditory Perceptual Disorders
1 approved drug
Cognitive Dysfunction
326 drugs (168 approved, 158 experimental)
Huntington Disease
90 drugs (43 approved, 47 experimental)
Phase 4 Indicated Drugs (57)
Phase 3 Indicated Drugs (36)
Phase 2 Indicated Drugs (63)
Other Experimental Indicated Drugs (103)
Organization Involved with Phase 4 Indications (35)
Organization Involved with Phase 3 Indications (21)
Organization Involved with Phase 2 Indications (27)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Drug Abuse (NIDA)
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (14)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.